Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial tags : Alliances save search
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Published: 2024-02-06 (Crawled : 14:00) - biospace.com/
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
collaboration trial sanofi
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
CYBN | $0.3746 -0.21% 560K
|
n/a
|
| O: 0.65%
H: 3.49%
C: 3.49%
first fibromyalgia treatment trial therapeutics
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
Published: 2023-12-13 (Crawled : 14:30) - biospace.com/
DTIL | $11.41 -0.87% 30K
|
Health Technology
|
| O: 0.34%
H: 4.84%
C: 2.33%
first approval arcus application program trial
Premier, Inc.’s PINC AI™ Applied Sciences (PAS) and TFS HealthScience Will Partner to Revolutionize Clinical Trials
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
PINC | $20.875 1.14% 250K
|
Health Services
|
| O: -0.14%
H: 1.79%
C: 1.32%
trials sciences
Cybin Announces Agreement with Fluence to Support Scaling of EMBARK Training for CYB003 Phase 3 Trial
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
CYBN | $0.3746 -0.21% 560K
|
n/a
|
| O: 6.6%
H: 6.4%
C: -13.69%
cyb003 trial agreement
Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate VERZENIO® (abemaciclib) in Combination with BBI-355 in Patients with CDK4 or CDK6 Amplified Solid Tumors
Published: 2023-09-19 (Crawled : 13:00) - biospace.com/
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: 0.06%
H: 1.19%
C: 0.58%
bbi-355 verzenio tumors collaboration trial agreement
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
Published: 2023-09-13 (Crawled : 13:00) - biospace.com/
ICLR | $298.435 2.2% 120K
|
Health Technology
|
| O: 1.04%
H: 2.23%
C: 1.98%
covid-19 trial
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
Published: 2023-09-13 (Crawled : 13:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.23%
H: 0.28%
C: 0.14%
adx-914 trial therapeutics
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial
Published: 2023-09-11 (Crawled : 13:00) - biospace.com/
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -3.31%
H: 1.02%
C: 0.97%
enhertu lung cancer tumor trial
HyBryte™ Expanded Treatment Trial in Cutaneous T-Cell Lymphoma Opens Enrollment
Published: 2023-08-10 (Crawled : 13:00) - biospace.com/
SNGX | $0.4406 -13.61% 4.3M
|
Health Technology
|
| O: 0.02%
H: 0.37%
C: -2.78%
t-cell treatment trial
Nektar Flags Lilly’s Miscalculations in Rezpeg Atopic Dermatitis Trials
Published: 2023-08-07 (Crawled : 15:00) - biospace.com/
NKTR | News | $1.295 -4.07% 1.1M
|
Health Technology
|
| O: 44.57%
H: 0.0%
C: 0.0%
dermatitis trials
Cybin Partners With Worldwide Clinical Trials to Support Future Clinical Development of CYB003 in Major Depressive Disorder
Published: 2023-07-26 (Crawled : 12:20) - biospace.com/
CYBN | $0.3746 -0.21% 560K
|
n/a
|
| O: 1.22%
H: 0.6%
C: -4.82%
cyb003 trials
Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers
Published: 2023-07-12 (Crawled : 12:20) - biospace.com/
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.29%
H: 0.49%
C: 0.26%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
hope beacon education novartis trial
Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
Published: 2023-07-10 (Crawled : 12:00) - biospace.com/
HWEL | $10.47 0.1% 7.6K
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
research global trial therapeutics
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Published: 2023-07-06 (Crawled : 14:00) - biospace.com/
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.71%
H: 0.19%
C: -1.57%
ARVN | $34.24 2.36% 220K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: -3.96%
collaboration trial therapeutics
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
Published: 2023-06-21 (Crawled : 12:00) - biospace.com/
PIRS | $0.163 3.76% 180K
|
Health Technology
|
| O: -58.66%
H: 5.38%
C: -29.51%
prs-060 pharmaceuticals trial study
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
Published: 2023-05-05 (Crawled : 12:00) - biospace.com/
ADTX | $2.35 21K
|
Health Technology
|
| O: 24.19%
H: 0.24%
C: -18.43%
research trial agreement study
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care
Published: 2023-05-01 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 4.08%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
health acquisition care trials collaboration sanofi
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
Published: 2023-04-25 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: -1.65%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: 0.0%
ALXO | $15.99 -0.56% 260K
|
Commercial Services
|
| O: -0.37%
H: 12.84%
C: 0.73%
collaboration trial sarclisa sanofi
Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical Trial
Published: 2023-04-13 (Crawled : 14:00) - biospace.com/
WBA P | $17.66 0.17% 1.6M
|
Retail Trade
|
| O: -0.06%
H: 0.34%
C: 0.31%
PRTA 4 | $20.68 -1.52% 180K
|
Health Technology
|
| O: 1.26%
H: 5.22%
C: 3.87%
disease alzheimer’s trial
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
HOLO | $2.86 27.68% 28M
|
XPON | $2.43 25.91% 7.2M
|
Your saved searches
Save your searches and get alerts when important news are released.